Price$11.63+0.23 (+2.06%)
01:30 PM02:30 PM
News · 26 weeks79-37%
2025-11-022026-04-26
Mix3990d
- Insider23(59%)
- Other5(13%)
- SEC Filings5(13%)
- Earnings3(8%)
- Analyst2(5%)
- Leadership1(3%)
Latest news
25 items- PRWellspect HealthCare Expands Surity™ Portfolio in the U.S. with Surity™ Male External Catheter for Urinary Incontinence CareMÖLNDAL, Sweden, April 30, 2026 /PRNewswire/ -- Today, Wellspect HealthCare launched the Surity™ Male External Catheter, a non-invasive solution for men living with urinary incontinence. This builds on the company's expanding portfolio of reliable urinary incontinence management solutions in the U.S., following the introduction of the Surity™ Female External Catheter earlier this year, and ahead of the anticipated launch of the Surity™ Urinary Management System. Severe urinary incontinence affects more than 13 million Americans and their caregivers, turning daily routines into o
- SECSEC Form DEFA14A filed by DENTSPLY SIRONA Inc.DEFA14A - DENTSPLY SIRONA Inc. (0000818479) (Filer)
- SECSEC Form DEF 14A filed by DENTSPLY SIRONA Inc.DEF 14A - DENTSPLY SIRONA Inc. (0000818479) (Filer)
- PRDentsply Sirona to Host First Quarter 2026 Conference Call on May 5CHARLOTTE, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will host an investor conference call and live webcast on Tuesday, May 5, 2026, at 4:30 p.m. ET to review its first quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call. Conference Call / Webcast Information The live webcast link and call information will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the c
- ANALYSTCitigroup initiated coverage on Dentsply Sirona with a new price targetCitigroup initiated coverage of Dentsply Sirona with a rating of Sell and set a new price target of $10.00
- INSIDERSEC Form 4 filed by Mazelsky Jonathan Jay4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by DENTSPLY SIRONA Inc.SCHEDULE 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)
- INSIDERSEC Form 4 filed by President, CEO & Member of BOD Scavilla Daniel T4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERSEC Form 4 filed by EVP, Chief Commercial Officer Denti Aldo Mariano Roberto4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERSEC Form 4 filed by VP, Chief Accounting Officer Czerney Kevin4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERDirector Lucier Gregory T bought $186,675 worth of shares (15,000 units at $12.45) (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERDirector Forbes James D bought $62,400 worth of shares (5,000 units at $12.48), increasing direct ownership by 100% to 10,000 units (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- PRFirst-ever Dental Dedicated MRI Validated in Clinical Trial and Cleared by FDA for Advanced Soft-Tissue DiagnosticsDentsply Sirona and Siemens Healthineers are pleased to announce that the first-ever dental-dedicated MRI1 (ddMRI) system – MAGNETOM Free.Max Dental Edition – has received FDA clearance in the United States. This milestone follows the completion of a clinical trial2 validating the system's significant potential across multiple dental specialties. The trial highlighted this first-of-its-kind technology's applicability in endodontics, periodontics, TMJ, tooth extraction, and orthodontics, offering non-ionizing imaging capabilities that can enhance diagnosis and treatment planning. CHARLOTTE, N.C., March 09, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona and Siemens Healthineers are pleased to sha
- INSIDERVP, Chief Accounting Officer Czerney Kevin was granted 13,690 shares, increasing direct ownership by 50% to 41,269 units (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERSVP, CHRO Frohning Andrea L. was granted 26,786 shares, increasing direct ownership by 72% to 63,992 units (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDEREVP, Chief Commercial Officer Denti Aldo Mariano Roberto was granted 59,524 shares (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERPresident, CEO & Member of BOD Scavilla Daniel T was granted 145,089 shares, increasing direct ownership by 866% to 161,839 units (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERSVP, Chief Supply Chain Office Johnson Robert Anthony was granted 44,643 shares, increasing direct ownership by 38% to 161,819 units (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERAmendment: SEC Form 4 filed by SVP, Chief Supply Chain Office Johnson Robert Anthony4/A - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERSVP, Chief Supply Chain Office Johnson Robert Anthony covered exercise/tax liability with 8,736 shares, decreasing direct ownership by 7% to 117,176 units (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERSVP, CHRO Frohning Andrea L. covered exercise/tax liability with 5,657 shares, decreasing direct ownership by 13% to 37,206 units (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERVP, Chief Accounting Officer Czerney Kevin covered exercise/tax liability with 2,052 shares, decreasing direct ownership by 7% to 27,579 units (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERDirector Lucier Gregory T bought $707,379 worth of shares (50,000 units at $14.15) (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERSVP, Chief Supply Chain Office Johnson Robert Anthony was granted 9,599 shares, increasing direct ownership by 8% to 125,912 units (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
- INSIDERSVP, CHRO Frohning Andrea L. was granted 8,861 shares, increasing direct ownership by 26% to 42,863 units (SEC Form 4)4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
XRAY FAQ
7 questionsWhat does DENTSPLY SIRONA Inc. do?
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The...Where does XRAY stock trade?
DENTSPLY SIRONA Inc. (XRAY) is listed on NASDAQ.What sector and industry is XRAY in?
DENTSPLY SIRONA Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did DENTSPLY SIRONA Inc. go public?
DENTSPLY SIRONA Inc. (XRAY) completed its IPO in 1987.What are analysts saying about XRAY?
DENTSPLY SIRONA Inc. has had 8 recent analyst actions on file. The most recent action was from Citigroup: Sell with a $1000.00 price target on 2026-04-15. Recent price targets range from $1000.00 to $2000.00.What companies are similar to XRAY?
Notable peers in the same industry include SYK (Stryker Corporation), BSX (Boston Scientific Corporation), MMM (3M Company), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare XRAY side-by-side with any of them on Quantisnow.How can I track XRAY on Quantisnow?
Quantisnow aggregates DENTSPLY SIRONA Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow XRAY to receive live email and push alerts on every new disclosure.